Prognostic Value of Blood Urea Nitrogen in Patients Hospitalized With Worsening Heart Failure: Insights From the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) Study
Journal of Cardiac FailurePublished 1 June 2007
Gerasimos Filippatos, Joseph S. Rossi, Donald M. Lloyd‐Jones, Wendy Gattis Stough, John Ouyang, David Shin
Citations165
SJR quartileQ1
SJR score2.16
SNIP1.49
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Higher baseline BUN is a powerful predictor of increased postdischarge mortality in patients hospitalized for heart failure, even in the absence of severe renal failure, and even mild to moderate elevations in baseline B UN were predictive.
Abstract
Higher baseline BUN is a powerful predictor of increased postdischarge mortality in patients hospitalized for heart failure, even in the absence of severe renal failure. Even mild to moderate elevations in baseline BUN were predictive. BUN remains an easily accessible risk stratification tool that physicians should closely monitor in the hospital setting.
Keywords
Medicine
American Heart JournalCharacteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
2,114 Citations2005Kirkwood F. Adams, Gregg C. Fonarow +7 more
The ADHERE demonstrates both the feasibility and significant implications of gathering representative data on large numbers of patients hospitalized with heart failure and provides important insights into the clinical characteristics and patterns of care of these patients.
JAMARisk Stratification for In-Hospital Mortality in Acutely Decompensated Heart Failure<SUBTITLE>Classification and Regression Tree Analysis</SUBTITLE>
1,586 Citations2005Gregg C. Fonarow
The results suggest that ADHF patients at low, intermediate, and high risk for in-hospital mortality can be easily identified using vital sign and laboratory data obtained on hospital admission and provides clinicians with a validated, practical bedside tool for mortality risk stratification.
JAMAPredicting Mortality Among Patients Hospitalized for Heart Failure
1,264 Citations2003Douglas S. Lee, Peter C. Austin +4 more
New England Journal of MedicineHormones and Hemodynamics in Heart Failure
1,197 Citations1999Robert W. Schrier, William T. Abraham
There is considerable evidence in support of a unifying hypothesis of the regulation of body-fluid volume that is applicable to patients with edematous disorders such as cardiac failure, and patients with .
JAMAShort-term Intravenous Milrinone for Acute Exacerbation of Chronic Heart Failure<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1,171 Citations2002Michael S. Cuffe
Journal of the American College of CardiologyThe prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction
876 Citations2000Daniel L. Dries, Derek V. Exner +3 more
The data suggest that, rather than simply being a marker of the severity of underlying disease, the adequacy of renal function may be a primary determinant of compensation in patients with heart failure, and therapy capable of improving renalfunction may delay disease progression.
JAMAEffects of Tolvaptan, a Vasopressin Antagonist, in Patients Hospitalized With Worsening Heart Failure<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
645 Citations2004Mihai Gheorghiade
Evaluating the short- and intermediate-term effects of tolvaptan in patients hospitalized with heart failure finds the vasopressin antagonist may increase net volume loss in heart failure without adversely affecting electrolytes and renal function.
Journal of Cardiac FailureThe prognostic importance of different definitions of worsening renal function in congestive heart failure
549 Citations2002Stephen S. Gottlieb, William T. Abraham +9 more
It is demonstrated that any detectable decrease in renal function is associated with increased mortality and prolonged hospital stay, and suggests that therapeutic interventions which improve renal function might be beneficial.
European Heart JournalThe severe cardiorenal syndrome: ‘Guyton revisited’
459 Citations2004Lennart G. Bongartz, Maarten J. Cramer +3 more
Journal of the American College of CardiologyPredischarge initiation of carvedilol in patients hospitalized for decompensated heart failure
374 Citations2004Wendy A. Gattis, Christopher M. O’Connor +3 more
Prischarge initiation of carvedilol in stabilized patients hospitalized for HF improved the use of beta-blockade at 60 days without increasing side effects or length of hospital stay.
The American Journal of MedicineElevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure
342 Citations2004Doron Aronson, Murray A. Mittleman +1 more
Blood urea nitrogen is a simple clinical variable that provides useful prognostic information in patients admitted for decompensated heart failure and probably reflects the cumulative effects of hemodynamic and neurohormonal alterations that result in renal hypoperfusion.
American Heart JournalOrganized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design
338 Citations2004Gregg C. Fonarow, William T. Abraham +7 more
The Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) program is designed to improve medical care and education of hospitalized patients with HF and accelerate the initiation of evidence-based HF guideline recommended therapies by administering them before hospital discharge.
Journal of Cardiac FailureRisk stratification after hospitalization for decompensated heart failure
328 Citations2004G. Michael Felker, Jeffrey D. Leimberger +6 more
Risk stratification of patients with decompensated HF may be accomplished using easily assessed clinical variables using multivariable modeling, and the discriminatory power of the model was substantial for the mortality model but less for the composite endpoint.
CirculationThe Clinical Challenge of Cardiorenal Syndrome
170 Citations2004Michael G. Shlipak, Barry M. Massie
Although renal dysfunction predicts all-cause mortality, it is most predictive of death from progressive heart failure, which suggests that it is a manifestation of and/or exacerbating factor for left ventricular dysfunction.
The American Journal of CardiologyEffect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure
169 Citations2004Mohammed W. Akhter, Doron Aronson +6 more
An increase in serum creatinine in the hospital results in a significantly longer length of stay and has an independent effect on long-term mortality.
American Heart JournalNeurohumoral control mechanisms in congestive heart failure
168 Citations1981Jay N. Cohn, T. Barry Levine +2 more
Preliminary encouraging experience with converting-enzyme inhibitors to block formation of angiotensin II and alpha-receptor blockers to inhibit norepinephrine-induced vasoconstriction raise the possibility that selective therapy may eventually have a place in long-term management of CHF.
American Heart JournalRationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure
44 Citations2003Mihai Gheorghiade, Wendy A. Gattis +5 more
A randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure.